What is CNTB's dilution risk score?

CNTB has a latest available DilutionScore record of 51/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for CNTB, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for CNTB?

DilutionWatch tracks 25 SEC filing types for CNTB including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect CNTB shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For CNTB, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for CNTB tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for CNTB. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

CNTB Dilution Risk Score: 51/100 (HIGH)

Score Breakdown

📋 Offering Ability

40

💰 Cash Runway

65

📊 Float Risk

65

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

⛅

Watch

Minor dilution signals detected

model est. 17%

🔄 Reverse Split model est. 25%

• 52-week low $0.73 has breached $1

• 7 months cash with weak price

💰 Capital Raise model 15%

• Under 12 months cash (7mo)

🔔 Track CNTB — Get forecast alerts →

Market Data

Market Cap$156.78M

Shares Outstanding62.97M

Float13.40M

Cash$31.49M

Debt$693.0K

Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

Field	Current Value	Basis
DilutionScore	51/100	DilutionWatch score record
Shares Outstanding	62.97M	Verified float table or market cache
Public Float	13.40M	Verified float table or market cache
Market Cap	$156.78M	Market data cache
Cash Runway	7.4 months	DilutionWatch score inputs
Shelf Capacity	None in current score inputs	SEC-derived dilution fields
ATM Capacity	None in current score inputs	SEC-derived dilution fields
Outstanding Warrants	None in current score inputs	SEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 0.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 3.0% shares (2026Q1 vs prior)

1 institutional holders · 1.2K shares

#1 EverSource Wealth Advisors, LLC 1.2K shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest1.99M

Days to Cover4.2

% of Float14.8%

FINRA data as of Aug 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

No recent SEC insights

Recent News

No recent news

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,348+ tracked stocks →

📖 Dilution Education

→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

More Research for CNTB

CNTB FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.

CNTB — Connect Biopharma Holdings Limited Dilution Risk Tracker